The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations

Immunology

Volumn 90, Issue 1, 1997, Pages 101-108

  Dayan, M ^a   Zinger, H ^a   Kalush, F ^a   Mor, G ^a   Amir Zaltzman, Y ^a   Kohen, F ^a   Sthoeger, Z ^a,b   Mozes, E ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b KAPLAN HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; ESTRADIOL ANTIBODY; ESTROGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; IMMUNOMODULATION; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031031550     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00122.x     Document Type: Article

References (43)

1. TAN E.M. (1989) Antinuclearantibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44, 93.
2. MENDLOVIC S., BROCKE S., SHOENFELD Y. et al. (1988) Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci USA 85, 2260.
3. ISENBERG D.A., SHOENFELD Y., MADAIO M.P. et al. (1984) Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 2, 417.
4. LAHITA R.G. (1986) The influence of sex hormones on the disease systemic lupus erythematosus. Springer Semin Immunopathol 9, 305.
5. KAHN C.R. & FLIER J.S. (1980) Clinical Immunology. Saunders Press, Philadelphia.
6. DUBOIS E.L. (1974) Lupus Erythematosus. University of Southern California Press, Los Angeles.
7. ROUBINIAN J.R., TALAL N., SIITERI P.K. & SADAKIAN J.A. (1979) Sex hormone modulation of autoimmunily in NZB/W mice. Arthritis Rheum 22, 1162.
8. ANSAR AHMED S. & PENHALE W.J. (1980) In: The Role of Sex Steroids in Autoimmune Thyroiditis (eds J.L Preud'home & V.A.L. Hauken) p. 14.3.02, Academic Press, Paris.
9. ROUBINIAN J.R., TALAL N., GREENSPAN J.S., GOODMAN J.R. & SIITERI P.K. (1979) Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest 63, 902.
10. BLANK M., MENULOVIC S., FRICKE H., MOZES E., TALAL N. & SHOENFELD Y. (1990) Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice. J Rheumutol 17, 311.
11. STHOEGER Z., BENTWICH Z., ZINGER H. & MOZKS E. (1994) The beneficial effect of the estrogen antagonist tamoxifen on experimental systemic lupus erythematosus. J Rheumatol 21, 2231.
12. DAYNES R.A., DUDLIY D.J. & ARANEO B.A. (1990) Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cell. Eur J Immunol 20, 793.
13. SARVETNICK N. & Fox H. (1990) Interferon gamma and the sexual dimerphism of autoimmunity. Molec Bidl Med 7, 323.
14. WEIGLE W.O. (1993) The effect of aging on cytokine release and associated immunologic functions. Immunol Problems in the Aged 13, 551.
15. VAN VOLLENHOVEN R.F., ENGLEMAN E.G. & McGUIRE J.L. (1994) An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 37, 1305.
16. DAYNKS R.A., MEIKLE A.W. & ARANEO B.A. (1991) Locally active steroid hormones may facilitate compartmentalization of immunity by regulating the types of lymphokines produced by helper T cells. Res Immunol 142, 40.
17. MOZES E., KALUSH F. & TARTAKOVSKY B. (1990) The physiological and pathological effects of cytokines. In: Progress in Leucocyte Biology (eds C.A. Dinarello, M.J. Kluger, M.C. Powanda & J.J. Oppenheim, p. 111. Willey-Liss, Inc. New York.
18. ROOK G.A.W., HERNANDEZ-PANDO R. & LIGHTMAN S.L. (1994) Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15, 301.
19. SHOENFELD Y., RAUCH J., MASSICOTTE H. et al. (1983) Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 308, 414.
20. KOHEN F. & LICHTER S. (1986) In: Monoclonal Antibodies: Basic Principles, Experimental and Clinical Applications in Endocrinology (eds G. Forti, M.B. Lipsett & M. Serio), p. 87. Raven Press, New York.
21. MENDLOVIC S., FRICKE H., SHOENFELD Y. & MOZES E. (1989) The role of anti-idiotypic antibodies in the induction of experimental SLE in mice. Eur J Immunol 19, 729.
22. DIGNAM J.D., LEBOVITZ R.M. & ROEDER R.G. (1983) Acurate transcription initiation by RNA polymerase 11 in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 11, 1475.
23. COLON P.J. (1983) A rapid biologic assay for the detection of interleukin 1. Immunology 134, 1280.
24. WILLIS S., FERM M.M. Ou W. & SMITH K.A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120, 2027.
25. HU-LI J., OHARA J., WATSON C., TSANG W. & PAUL W.E. (1989) Derivation of a T-cell line that is highly responsive to IL-4 and IL-2 (CT. 4R) and of an IL-2 hyporesponsive mutant of that line (CT. 4S). J Immunol 142, 800.
26. MOSMANN T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65, 55.
27. DAVIDSON N.E. (1992) Tamoxifen panacea or pandora's box? N Engl J Med 326, 885.
28. FISHER B., BROWN A. & WOLMARK H. (1987) Prolonging tamoxifen therapy for primary breast cancer. Ann Intern Med. 106, 649.
29. STEINBERG A.D., ROTHS J.B., MURPHY D.E., STEINBERG R.T. & RAVECHE E.S. (1980) Effects of thymectomy or androgen administration upon the autoimmune disease of MRL-lpr/lpr mice. J Immunol 125, 871.
30. DUVIC M., STEINBERG, A.D. and KLASSHN L.W. (1978) Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum 21, 414.
31. OHNISHI K., EBLING F.M., MITCHELL B., SINGH R.R., HAHN B.B. & TSAO B.P. (1994) Comparison of pathogenic and nonpathogenic murine antibodies to DNA: antigen binding and structural characteristics, Int Immunol 6, 817.
32. BESEDOVSKY H. & DEL REY A. (1992) Feed-back interactions between immunological cells and the hypothalamus pituitary adrenal axis. Neth J Med. 39, 274.
33. BATEMAN A., SINGH A., KRAL T. & SOLOMON S. (1989) The immune hypothalmic pituitary-adrenal axis. Endocr Rev. 10, 92.
34. HERMUS, A.R.M.M. and SWEEP C.G.J. (1990) Cytokines and the hypothalmic-pituitary adrenal axis. J Steroid Biochem Mol Biol 37, 867.
35. BERNTON E.W., BEACH J.E., HOLADAY J.W., SMALLRIDGE R.C. & FEIN H.G. (1987) Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science. 348, 519.
36. BARANAO R.I. TENENBAUM A.E., SALES M.E. & RUMI L.S. (1992) Functional alterations of murine peritoneal macrophages during pregnancy. Am J Repro Immunol 27, 82.
37. SPANGELO B.L., JUDD A.M., ISAKSON P.C. & MACLEAD R.M. (1989) Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125, 575.
38. ARZT E., BURIC R., STELZER G. et al. (1993) Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132, 459.
39. KARANTH, S. and MCCANN S.M. (1991) Anterior pituitary hormone control by interleukin-2. Proc Natl Acad Sci 88, 2961.
40. TOMINAGA T., FUKATA J., NAITO Y. et al. (1991) Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins. Endocrinology 128, 526.
41. DENICOFF K.D., DURKIN T.M., LOTZH M.T. et al. (1989) The neuroendocrine effects of interleukin-2 treatment. J Clin Endocrinol Metab 69, 402.
42. NAITO Y., FUKATA J., TOMINAGA T. et al. (1989) Adrenocorticotropic hormone-releasing activities of interleukins in a homologous in vivo system. Biochem Biophys Res Commun 164, 1262.
43. SEGAL R., DAYAN M., ZINGER H. & MOZES E. (1995) Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation. Clin Exp Immunol 101, 66.